这几天生物科技板块大跌 和上周希拉里提出计划要抵制“哄抬药价”有关

希拉里称将提出一项计划，抵制制药商的价格欺诈行为。希拉里的这一表态，是在回应周日纽约时报的一篇文章，文章称一种用于治疗寄生虫感染的药物价格，近期从13.5美元提升到750美元。受此影响，美股生物科技股板块重挫4.6%。

周日，纽约时报的一篇文章报道，一种用于治疗寄生虫感染的药物价格，近期从13.5美元提升到750美元。价格发生这一变化，只是由于Turing制药公司获得了药物权力，药物本身并未发生变化。

为此，希拉里发表推文称，专业药品市场上，像这样的价格欺诈是离谱的。明天，我会拟定计划，旨在抵制这种行为。

 

Democrats take aim at drug prices, prompting sharp drops in biotech stocks

Mon Sep 28, 2015 3:06pm EDT

 

Democratic lawmakers attacked "massive" price increases of two heart drugs from Canada's Valeant Pharmaceuticals International Inc, sparking a rout in drugmakers' shares on worries of a broad government and insurer clamp down on U.S. drug prices.

All 18 Democratic members of the House Committee on Oversight and Government Reform urged their chairman on Monday to subpoena Valeant to force it to provide documents relating to price increases of 212 percent and 525 percent, respectively, for Isuprel and Nitropress, immediately after buying the heart drugs in February.